Continuous veno-venous hemofiltration for severe acute pancreatitis
Continuous veno-venous hemofiltration for severe acute pancreatitis
复制标题
连续性静脉-静脉血液滤过治疗重症急性胰腺炎
DOI：
10.1002/14651858.cd012959.pub2
复制
发表时间：
2019
影响因子：
8.4
通讯作者：
Cheng Y
中科院分区：
文献类型：
--
作者：
Lin Y;He S;Gong J;Ding X;Liu Z;Gong J;Zeng Z;Cheng Y
背景严重的急性胰腺炎与高死亡率和危及生命的并发症有关。连续性静脉-静脉血液滤过(CVVH)已被一些中心用于降低死亡率和避免局部或全身并发症，但其有效性和安全性尚不确定。目的评估CVVH在重症急性胰腺炎患者中的益处和危害，比较不同CVVH技术的效果，并评价CVVH的最佳投放时间。
BackgroundSevere acute pancreatitis is associated with high rates of mortality and life‐threatening complications. Continuous veno‐venous hemofiltration (CVVH) has been used in some centers to reduce mortality and avoid local or systemic complications; however, its efficacy and safety are uncertain.ObjectivesTo assess the benefits and harms of CVVH in patients suffering from severe acute pancreatitis; to compare the effects of different CVVH techniques; and to evaluate the optimal time for delivery of CVVH.